Press Releases

	Jerusalem, Israel, July 23, 2008, July 23, 2008 Teva Completes Acquisition of Bentley Pharmaceuticals
	Jerusalem, Israel, July 23, 2008 Teva Introduces First Generic Lamictal® Tablets in the United States
	Jerusalem, Israel, and Montvale, New Jersey, July 18, 2008 Teva and Barr Invites Public to Listen to Webcast
	Jerusalem, Israel and Montvale, NJ, July 18, 2008 Teva to Acquire Barr
	Jerusalem, Israel and Lund, Sweden, July 16, 2008 Teva Enrolls Patients for a Second Large Global Phase III Trial Of Oral Laquinimod
	Jerusalem, Israel, July 14, 2008 ADAGIO Phase III Top Line Data to be Presented at 12th Congress of European Federation of Neurological Societies
	Jerusalem, Israel, July 14, 2008 Teva to Report Second Quarter 2008 Financial Results on July 29, 2008
	Jerusalem, Israel, July 11, 2008 Teva Pharmaceutical Industries Ltd. Statement Regarding COPAXONE®
	Jerusalem, Israel, July 11, 2008 Teva Comments on Paragraph IV Filing for COPAXONE®; Intends to File Lawsuit against Generic Filer for Patent Infringement
	Jerusalem, Israel, July 7, 2008 Teva Provides Update on FORTE Trial
	Jerusalem, Israel, June 30, 2008 Teva Receives First U.S. Approval For Generic Risperdal® Tablets; Commences Commercial Launch
	Jerusalem, Israel & Melbourne, Australia, June 30, 2008 Teva & ANP Announce That ATL/TV1102, a Novel Drug for The Treatment of Relapsing Remitting Multiple Sclerosis (RRMS), Demonstrated Significant Reduction In Disease Activity
	Jerusalem, Israel, June 24, 2008 Teva to Present at The Piper Jaffray Third Annual Europe Conference
	Jerusalem, Israel, June 16, 2008 Teva's AZILECT® 1 mg Tablets Meet End Points in ADAGIO Phase III Trial
	Jerusalem, Israel, June 12, 2008 Teva Announces Tentative Approval of Generic Diovan® Tablets
	Jerusalem, Israel, June 11, 2008 Teva to Present at the Goldman Sachs 29th Annual Global Healthcare Conference
	Jerusalem, Israel, May 30, 2008 Teva Announces Launch of Generic Wellbutrin Xl® Tablets, 150 Mg
	Jerusalem, Israel, May 27, 2008 Teva To Present At The UBS Global Specialty and Generic Pharmaceuticals Conference
	Jerusalem, May 21, 2008 Teva Announces Approval Of Generic Sarafem® Pulvules®
	Jerusalem, Israel, May 12, 2008 Teva To Present At The Bank Of America Health Care Conference
	Jerusalem, Israel, May 6, 2008 Teva Reports First Quarter 2008 Results
	Jerusalem, Israel, April 30, 2008 Teva Announces Global In-Market First Quarter Sales Of Copaxone® Increased 35% To $542 Million
	Jerusalem, Israel, April 28, 2008 Teva Announces Approval Of Generic Flolan® For Injection
	Jerusalem, Israel, April 23, 2008 Teva To Report First Quarter 2008 Financial
	Jerusalem, April 17, 2008 Teva Announces Tentative Approval Of Generic Evista® Tablets
	Jerusalem, April 17, 2008 Teva Announces Tentative Approval Of Generic Maxalt® Tablets
	Jerusalem, April 16, 2008 Early Treatment With Copaxone® Significantly Delayed Progression To Clinically Definite Multiple Sclerosis
	Jerusalem, Israel, April 11, 2008 Teva Announces Brussels Court Decision To Revoke MSD's European Patent On Fosamax®
	Jerusalem, Israel, April 11, 2008 Teva Receives Court Ruling Awarding Exclusivity For Generic Risperdal®
	Jerusalem, Israel, April 10, 2008 Copaxone® Significantly Reduced Annual Relapse Rates And Stabilized Disease Progression In Relapsing Remitting Multiple Sclerosis Patients Failing Interferon Treatment
	Jerusalem, Israel, March 31, 2008 Teva Provides Update On Generic Prevacid® Litigation
	Jerusalem, Israel and Exeter, NH, March 31, 2008 Teva to Acquire Bentley Pharmaceuticals
	Jerusalem, Israel, March 28, 2008 Teva Provides Update On Generic Aricept® Litigation
	Jerusalem, Israel, March 25, 2008 Teva Reports 2007 Financials in XBRL Standard
	Jerusalem, Israel, March 17, 2008 Teva to Present at the Lehman Brothers 11th Annual Global Healthcare Conference and at the Cowen and Company 28th Annual Healthcare Conference
	Jerusalem, Israel, March 13, 2008 Teva Provides Update On Glatiramer Acetate 40mg For Amyotrophic Lateral Sclerosis (ALS)
	Jerusalem, Israel, March 12, 2008 Teva To Present At The Bear Stearns 10th Annual London Healthcare Conference
	Jerusalem, Israel, March 5, 2008 Teva Provides Update On Generic Risperdal®
	Jerusalem, Israel, February 29, 2008 Teva Provides Update On Generic Actonel® Litigation
	Jerusalem, Israel, February 28, 2008 Teva Announces Approval Of Generic Camptosar®
	Jerusalem, Israel, February 25, 2008 Teva Announces Two Court Decisions to Revoke MSD's European Patent on Generic Fosamax®
	Jerusalem, Israel, February 21, 2008 Teva's Developed G-CSF is the First Biosimilar to Receive a Positive Opinion from European Union Regulators
	Jerusalem, Israel, February 21, 2008 Teva Presents Growth Strategy At Investor Day Company Provides Long Term Strategic Goals Teva Announces Closing Of Cogenesys Acquisition
	Jerusalem, Israel, February 19, 2008 Teva Invites Public To Listen To Investor Day Webcast
	Jerusalem, Israel, February 12, 2008 Teva Provides 2008 And 2009 Financial Outlook
	Jerusalem, Israel, February 12, 2008 Teva Reports Fourth Quarter And Full Year 2007 Results
	Jerusalem, Israel, February 6, 2008 Teva Announces Approval of Generic Fosamax® Tablets
	Jerusalem, Israel, February 1, 2008 Teva Provides Update On Generic Protonix®
	Jerusalem, Israel, January 31, 2008 Teva Announces Tentative Approval Of Generic Flomax® Capsules
	Jerusalem, Israel, January 30, 2008 Teva Announces Wyeth Voids Standstill Agreement On Generic Protonix®
	Jerusalem, Israel, January 29, 2008 Teva To Present At The 2008 Wachovia Healthcare Conference
	Jerusalem, Israel, January 29, 2008 Teva To Report Fourth Quarter And Full Year 2007 Financial Results On February 12, 2008
	Jerusalem, Israel, January 23, 2008 Teva Announces Tentative Approval Of Generic Prevacid® Delayed-Release Capsules
	Jerusalem, Israel, January 22, 2008 Teva Announces Extension To Standstill Agreement On Generic Protonix®
	Jerusalem, Israel, January 22, 2008 Teva to Acquire CoGenesys Acquisition Will Bolster Teva's Biotechnology Capabilities
	Jerusalem, Israel, January 17, 2008 Teva Announces Approval Of Pravastatin Sodium Tablets, 80 Mg
	North Wales, Pa. and Atlanta, January 16, 2008 Teva Specialty Pharmaceuticals And UCB Announce U.S. Respiratory Collaboration Agreement
	Jerusalem, Israel, January 14, 2008 Teva Announces Tentative Approval Of Generic Aricept® Tablets
	Jerusalem, Israel, January 14, 2008 Teva to Explore Strategic Alternatives for its Animal Health Business
	Jerusalem, Israel, January 10, 2008 Teva Announces Departure Of North American CEO , William S. Marth To Become Ceo Of Teva North America
	Jerusalem, Israel, January 3, 2008 Teva To Present At The Morgan Stanley Pharmaceutical CEO's Unplugged Conference And At The 26th Annual Jpmorgan Healthcare Conference
	Jerusalem, Israel, January 3, 2008 Teva Announces Approval Of Generic Kytril® Injection And Tablets
	Jerusalem, Israel, January 2, 2008 Teva Announces Approval Of Generic Duoneb®